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ABSTRACT
Photoageing and skin cancer are major causes of morbidity
and are a high cost to society. Interest in the development of
photoprotective agents for inclusion in topical cosmetic and
sunscreen products is profound. Recently, amino acids with a
sulfinic group, notably hypotaurine, have been included as
ingredients in cosmetic preparations. However, the mecha-
nism of action of hypotaurine as a possible anti-aging agent
is unknown, despite its use as a free radical scavenger. To
address this issue, we investigated hypotaurine uptake in a
human keratinocyte model and examined its effect on UVR-
induced cytotoxicity. Hypotaurine was taken up by ker-
atinocytes in a time- and concentration-dependent manner,
with levels remaining significantly above baseline 48 h after
washout. A cytoprotective effect of pre-incubation with 2.5–
5 mMhypotaurine was shown as indicated by increased cell
viability when keratinocytes were irradiated with UVA at 5
or 10 Jcm-2, with the level of hypotaurine also significantly
reduced. These findings indicate a potential cytoprotective
effect of hypotaurine against the deleterious effects of UVA
irradiation. This provides support for further studies to eval-
uate the potential photoprotective benefits of hypotaurine
supplementation of topical cosmetic and sunscreen products.
Abbreviations: PPG, propargylglycine; ROS, reactive oxygen
species; TAUT, taurine transporter.
INTRODUCTION
Photoageing and skin cancer are consequences of cumulative
cutaneous exposure to ultraviolet radiation (UVR) and are
increasingly major causes of morbidity, placing huge burdens on
society and health service provision and having important eco-
nomic impact (1–3). In addition to the harmful effects of UVR
on skin, induction of several protective mechanisms is also initi-
ated, including production of enzymatic and non-enzymatic
antioxidants that interact with reactive oxygen species (ROS) to
minimize oxidative damage (4). However, UVR-induced oxida-
tive stress may overwhelm natural cutaneous antioxidant capabil-
ities, resulting in the induction of cell death or survival of
aberrant cells that are in turn implicated in the processes of pho-
tocarcinogenesis and photoageing (5,6). UVA irradiation in ker-
atinocytes increases hydrogen peroxide (H2O2) levels followed
by conversion to hydroxyl radical, which seems to be a major
contributor to UVA-induced damage in keratinocytes (7). In
recent decades, considerable efforts have been made to prevent
or limit oxidative stress-induced harmful effects of UVR on
human skin, notably through supplementation with antioxidants,
which are increasingly included in topical anti-aging, photopro-
tective and cosmetic products (8,9).
The sulfinic acid, hypotaurine has been identified as a poten-
tial active ingredient for inclusion in such preparations in order
to minimize or prevent oxidative skin damage (10). Hypotaurine
is a sulfur amino acid, characterized by the presence of a sulfinic
group rather than a carboxyl group, which can be oxidized to
taurine (11,12) through a non-enzymatic reaction upon interac-
tion with ROS such as hydroxyl radical (13). The ability of
hypotaurine to react with ROS or other radical species, such as
nitrogen dioxide radicals or carbonate radical anions, has been
shown in kinetic experiments using isolated superoxide dismu-
tase enzyme or by pulse radiolysis (14,15). Hypotaurine has been
shown to have a protective effect against oxidative stress-induced
damage in rat placental trophoblasts (16) as well as in human
skin fibroblast models of cigarette smoke-induced oxidation (17).
Whilst the potential roles of hypotaurine in human skin are
largely unexplored, taurine has been more thoroughly investi-
gated in different skin models, particularly in its roles as an
osmolyte involved in maintaining skin barrier homeostasis and in
protecting against epidermal and keratinocyte dehydration, in
addition to protection against UV-induced apoptosis in epidermal
keratinocytes and retinal ganglion cells (18–22). The photopro-
tective effect of taurine has been demonstrated by upregulation
of both taurine and its transporter (TAUT) following UVB expo-
sure of human keratinocytes (22) and in a TAUT deficient mouse
model showing increased sensitivity to UVB-induced immuno-
suppression due to a role for taurine in regulating UVB-induced
hydrolysis of membrane lipids and release of the immunosup-
pressive molecule platelet-activating factor (21).
The localization of taurine in skin has been investigated, with
high levels found in the granular and upper spinous layers of rat
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and dog epidermal keratinocytes, but absent in stratum corneum,
basal and lower spinous layers (23). Taurine is not evenly dis-
tributed in the skin and its quantification in human excised skin
layers has shown it to be most abundant in the epidermis (~250 µg
taurineg1 skin layer) and with lower concentrations in increas-
ingly deeper layers of the dermis and in the stratum corneum
(~50 µg taurineg1) (24). The distribution of the taurine trans-
porter (TAUT) has also been investigated and has been shown to
be detectable in the epidermis with a distribution gradient from the
spinous to granular layers but not the dermis, using Western blot
analysis (using a polyclonal anti-TAUT antibody) (20). Taurine
uptake into keratinocytes against a concentration gradient has also
been demonstrated and hypotaurine used as competitor has shown
a reduction of taurine confirming that TAUT accept hypotaurine
(25). Interestingly, hypotaurine has also been shown to be a sub-
strate for TAUT/slc6a6 in keratinocytes (25) and GABA trans-
porter family member (GAT2/Slc6a13) in human embryonic
kidney (HEK293) cells (26), confirming that hypotaurine can be a
substrate for TAUT in human skin. Moreover, hypotaurine uptake
mediated by TAUT and GAT2 has been shown to contribute to the
cellular resistance to oxidative stress (26).
Taurine does not directly react with ROS (27) and its protec-
tive activity in epidermal keratinocytes against dehydration or
UV-induced apoptosis has been shown to be related to its role as
an osmolyte (19,20). On the contrary, the taurine precursor,
hypotaurine reacts efficiently and directly with ROS, including
hydroxyl radicals, superoxide anions and singlet oxygen (15,27).
Moreover, considering UVA induces ROS and intracellular
levels of hydrogen peroxide, which can further generate hydroxyl
radicals (7,28), hypotaurine could potentially play a major role in
protecting against UVR-induced oxidative damage.
The aims of this study were to investigate hypotaurine uptake
in cultured human keratinocyte (HaCaT) cells, to assess its
potential in protection against UVR-induced oxidative damage
and to evaluate its potential value for inclusion in sunscreen and
cosmetic products.
MATERIALS AND METHODS
Cell culture and test treatments. HaCaT human keratinocytes (Interlab
Cell Line Collection) were routinely cultured in DMEM with 10% FBS,
2% GlutaMAXTM and 1% Sodium Pyruvate in 5% CO2 at 37°C. In all
test conditions, cells were allowed to adhere for 24 h before any
treatment and were seeded as follows: MTT assay 2.5 9 103 cells/well in
96-well plates; NRU assay 1 9 104 cells/well in 96-wells plates; HPLC
1 9 105 cells/well in 12-well plates. The test compounds hypotaurine,
taurine, b-alanine and DL-Propargylglycine cystathionine c-lyase
inhibitor (PPG) were diluted in culture media to the concentrations and
for the times indicated in the figure legends. Control cells were analyzed
after 24 h in culture and were untreated.
Trypan blue. After treatment, the media was removed, and cells were
incubated with 1mL EDTA for 10’. The ETDA was removed and 1 mL
trypsin was added for 1’ at 37°C. Cells were collected and centrifuged
for 5’ at 160 g at room temperature and resuspended in 1 mL media.
100 µL of trypan blue was added to 100 µL of cells and mixed. 10 µL
of sample were added in the Neubauer chamber and cells were counted
under microscope.
MTT assay. AThiazolyl Blue TetrazoliumBromide (MTT) stock solution
(5 mg mL1 in PBS)was prepared 24 h in advance and stored in freezer. The
day of the assay, MTT aliquot was warmed in water-bath for 15’ and 25 µL
was added to each well at a final concentration of 1 mg mL1 and incubated
at 37°C for 2 h. After which the MTT was removed, the wells washed with
100 µL PBS and 100 µLDMSO added (29) and mixed with a plate shaker for
5’ protected from light with tinfoil. Optical density was read at 570 nm
with 690 nmsubtractionusing aBioTeck–Synergy2microplate reader.
NRU assay. A NR stock solution was prepared 24 h in advance at
37°C protected from light (1:10 dilution in PBS to 0.33 mg mL1 from
N2889-20ML Sigma) (30). The day of the assay, 20 µL of
0.33 mg mL1 (NR solution) was added to each well directly into
treatment media to have a final concentration of 55 µg mL1 and
incubated at 37°C for 2 h. Half an hour before the end of NR incubation,
the NR destain solution was prepared as followed: 50% (v/v) EtOH in
ddH2O containing 1% (v/v) glacial acetic acid, and kept in ice. After the
2 h, the NR solution was removed and the wells washed with 100 µL
EBSS, carefully removed within 1 min. The plate was left drying for 2’
and 100 µL NR destain solution added and mixed with a plate shaker for
10’ protected from light with tinfoil. After, optical density was read at
540 nm using a BioTeck-Synergy 2 reader.
HPLC analysis. Hypotaurine uptake was analyzed by HPLC as
described in (13). Briefly, after treatment, cells were collected by
centrifugation for 5’ at 160 g at room temperature following treatment
with EDTA and trypsinization. The cell pellets were lysed with 500 µL
of cold lysis buffer (0.1 M HCl with 0.2% TDGA), vortexed and
incubated at 4°C for 5’. Lysed cells were centrifuged for 10’ at 160 g
and 10 lL of supernatant was taken and derivatize for 2’ with 25%
OPA-mercaptoethanol (0.2 M OPA in 1 mL methanol, 5 mL of borate
buffer and 40 lL mercaptoethanol) and 65% borate buffer (0.81 M boric
acid, 0.79 M potassium hydroxide in 100 mL dH2O) in a 100 lL final
volume. Total protein was quantified by BCA assay using bovine serum
albumin standard. 50 lL of sample were analyzed by HPLC after 2’
incubation. HPLC analysis was performed with Varian ProStar HPLC
fluorimetric equipment and Phenomenex column (Gemini C18, 5 µM,
250 9 4.6 mm). The excitation was performed at 340 nm and the
emission at 450 nm. The mobile phase A was prepared with 0.05 M
sodium acetate at pH 5.5: methanol (80:20, v/v), and mobile phase B
with methanol: H2O (80:20, v/v). Flow rate was 1 mL min
1 at 20°C
and the elution gradient was linear from phase A to 50% phase B in 5’
followed by isocratic at 50% phase B (13).
UVA irradiation. Philips Cleo (100W-R) lamp with a 320–395 nm
range (kmax: 365 nm), with 320 nm cut off glass filtering was used to
reach 3.4 mW cm2 UVA intensity (as assessed using a calibrated UV
light meter: IL-1400A International Light INC. Newburyport,
Massachusetts) approximately 10 cm from the plates. UVA doses of 5,
10 and 15 Jcm-2 were reached with 24, 48 and 72 min of irradiation
respectively. Before irradiation, cells were treated for
24 h  hypotaurine, then washed with PBS and incubated in fresh FBS-
free media for irradiation. After the irradiation, cells were washed with
PBS and incubated for 24 h in fresh media. The % viability was
calculated by comparison to control cells which were also placed under
the light source but shielded (dark).
Statistical analysis. Statistical analysis was performed using GraphPad
Prism-7.03, and data expressed as mean  standard deviation (SD) with
3–6 replicates in 3 independent experiments for cell viability (MTT and
NRUA) and 2–3 replicates in 2–3 independent experiments for HPLC.
Statistical significances were analyzed using the two-tailed non-parametric
t-test (Mann–Whitney’s correction) for Figures 1,4 and 6 to compare the
means between 2 groups or the one-way ANOVA (Dunnett’s correction)
for Figures 2, 3 and 5 between 3 and more groups.
RESULTS
Hypotaurine supplementation enhances HaCaT cell viability
To assess the effect of hypotaurine supplementation of culture
media on intracellular levels, HaCaT cells were initially cultured
for 24 h with  5 mM hypotaurine as this concentration has
been used in taurine accumulation studies (20,23). The intracellu-
lar hypotaurine concentration was determined by HPLC analysis
(Fig. 1a), which shows that hypotaurine levels were significantly
increased in cells from 0.21  0.2 nmol mg1 protein in
untreated cells to 9.87  0.8 nmol mg1 protein (*P < 0.05).
Although the concentration decreased 24 and 48 h after hypotau-
rine washout, levels remained significantly higher than baseline
values. The impact of 5 mM hypotaurine supplementation for
24 h on cell viability was assessed by MTT assay (Fig. 1b).
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When compared to untreated cells, hypotaurine supplementation
was associated with a small but significant increase in cell viabil-
ity at the 48 h washout time (**P < 0.01).
Uptake of supplemental hypotaurine in HaCaT cells occurs
in a time-dependent manner
To investigate whether increasing the time of hypotaurine sup-
plementation resulted in increased cellular uptake, the intracellu-
lar concentration in HaCaT cells cultured with  5 mM
hypotaurine for 2–72 h was determined by HPLC analysis
(Fig. 2). Hypotaurine levels were significantly increased in cells
from 2 h and reached a maximum at 10 h
(14.2  0.1 nmol mg1 protein), with levels remaining signifi-
cantly increased and stable until 72 h (Fig. 2). As the level of
hypotaurine remained significantly elevated from 8h to 72h but
without a statistical difference between these timepoints, subse-
quent experiments were performed following 24 or 48 h incuba-
tion to enable the longer-term effects to be assessed.
Uptake of supplemental hypotaurine in HaCaT cells occurs
in a concentration-dependent manner
To determine whether increasing the concentration of supplemen-
tal hypotaurine resulted in increased cellular uptake, HaCaT cells
were treated for 24 h with hypotaurine (0.05–40 mM) and the
intracellular hypotaurine concentrations were determined by
HPLC analysis (Fig. 3a). This range of hypotaurine concentra-
tions was selected for analysis as the lower levels reflect the
amount of taurine present in epidermal tissue (23), whilst the
higher levels are in line with the hypotaurine concentrations pre-
sent in cosmetic cream (~18 mM) (10). Whilst increased intracel-
lular hypotaurine was detectable at all levels of supplementation
compared to untreated cells (ctr), the uptake was only signifi-
cantly increased at concentrations above 2.5 mM, after which an
exponential increase in hypotaurine accumulation was seen. The
highest concentration investigated was 40 mM hypotaurine, with
cellular uptake of 32.7  2.0 nmol mg1 protein (Fig. 3a). The
impact of hypotaurine uptake on cell viability was assessed by
both MTT and NRU assay following the treatment of cells with
hypotaurine (0.05–40 mM) for 24 h (Fig. 3b). The NRU assay
was performed and used as dark control for following UVA
experiments. Hypotaurine supplementation above 5 mM was
associated with a reduction in cell viability that was significantly
decreased at 20 and 40 mM (83.7  8.1 % and 69.7  6.4 %;
Fig. 3b (MTT)). In contrast, when viability was assessed by neu-
tral red uptake (NRU) assay, no significant impact on cell viabil-
ity was observed (Fig. 3b). Using trypan blue exclusion as an
indicator of live cell number after hypotaurine treatment at 0, 1,
5 and 20 mM did not show a reduction in viable cell number
(1.6 105  0.06 cells mL1 at 20 mMvs 1.56 105  0.08
cells mL1 at 0 mM, similar results for 1 and 5 mM).
Inhibition of hypotaurine transport or of taurine metabolic
synthesis impacts on cellular hypotaurine uptake and
viability
Hypotaurine has previously been shown to be a substrate for the
taurine transporter TAUT (25,26), so we first investigated
whether the presence of the TAUT substrates, taurine or b-ala-
nine (25), affected hypotaurine uptake and cell viability. Incuba-
tion of HaCaT cells with or without b-alanine prior to
supplementation with hypotaurine or hypotaurine plus taurine
Figure 1. Hypotaurine supplementation enhances HaCaT cell viability. HaCaT cells were cultured with 0 or 5 mM hypotaurine for 24 h after which,
they were washed with PBS to remove excess hypotaurine from media and incubated in fresh media for the indicated washout times (24 and 48 h). (a)
Following cell lysis, intracellular hypotaurine levels were detected by HPLC and normalized to total protein. (b) Cell viability was determined by MTT
assay and normalized to untreated cells. Graphs show the means and error bars represent the SD of 3 replicates in 3 independent experiments. For com-
parison of untreated and hypotaurine treated cells: *P < 0.05, **P < 0.01 (Student t-test).
Figure 2. Uptake of supplemental hypotaurine in HaCaT cells occurs in
a time-dependent manner. HaCaT cells were treated with 5 mM hypotau-
rine up to 72 h. Control cells were analyzed after 24 h in culture and
were not treated with hypotaurine. Following cell lysis, intracellular
hypotaurine was detected by HPLC and levels normalized to total pro-
tein. Graph shows the means and error bars represent SD of 2 replicates
in 2–3 independent experiments. For comparison using ctr as control:
*P < 0.05, ***P < 0.005 (ANOVA test).
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showed no significant impact on cell viability (Fig. 4a left and
middle). The presence of taurine resulted in a significant decrease
in the uptake of hypotaurine (5.8  0.8 nmol mg1 protein)
compared to hypotaurine alone (9.87  0.8 nmol mg1 protein;
Fig. 4b, left). HaCaT cells were treated for 24 h in presence of
5 mM b-alanine or 2 mM propargylglycine (PPG), washed in
PBS and incubated for a further 24 h with hypotaurine or
hypotaurine plus taurine. Incubation with b-alanine prior to sup-
plementation with hypotaurine enhanced hypotaurine uptake into
cells (18.6  1.2 nmol mg1 protein; Fig. 4b, middle) to levels
above those seen with hypotaurine alone (Fig. 4b, left), but this
was prevented in the presence of taurine where levels were com-
parable to hypotaurine alone.
Propargylglycine (PPG) inhibits the metabolic synthesis of
taurine by blocking the decarboxylation of cysteinesulfinate to
hypotaurine by acting on the cysteinesulfinate decarboxylase
enzyme responsible for this reaction (31). We investigated
whether the presence of PPG affected hypotaurine uptake and
cell viability, where HaCaT cells pre-treated with PPG are
capable of reducing hypotaurine levels (31). As with b-alanine,
incubation with PPG for 24 h prior to supplementation with
hypotaurine enhanced hypotaurine uptake into cells
(17.9  1.2 nmol mg1 protein; Fig. 4b, right) above hypotau-
rine alone (Fig. 4b, left). Again, this enhancement was prevented
by co-incubation with taurine, where levels of intracellular
hypotaurine were comparable to hypotaurine alone, and signifi-
cantly higher than with hypotaurine plus taurine. In addition, cell
viability was reduced for both hypotaurine alone and hypotaurine
plus taurine after pre-incubation with PPG (81.0  3.5 % and
77.3  1.5 % respectively; Fig. 4a).
Hypotaurine supplementation protects against UVA-induced
cell damage
To investigate whether hypotaurine supplementation could pro-
tect against UVA-induced cell damage, keratinocytes were UVA
irradiated at three different doses in the absence or in the pres-
ence of hypotaurine. Oxidative damage caused by intracellular
Figure 3. Uptake of supplemental hypotaurine in HaCaT cells occurs in a concentration-dependent manner. HaCaT cells were treated for 24 h with
increasing concentrations of hypotaurine from 0.05 to 40 mM. (a) Following cell lysis, intracellular hypotaurine was detected by HPLC and levels nor-
malized to total protein quantified. (b) Cell viability was determined by MTT and NRU assay and normalized to untreated cells (ctr). Graphs show the
means and error bars represent SD of 3 replicates in 3 independent experiments. For comparison using the respective assay ctr as control: *P < 0.05,
**P < 0.01 and ***P < 0.005 (ANOVA test).
Figure 4. Inhibition of TAUT or of taurine metabolic synthesis impacts on cellular uptake and viability. HaCaT cells were treated for 24 h in presence
and absence of 2 mM propargylglycine (PPG) or 5 mM b-alanine (b-ALA), washed in PBS and incubated for a further 24 h with 5 mM hypotaurine
( ) or 5 mM each of hypotaurine plus taurine ( ). (a) Cell viability was determined by MTT assay and normalized to treatment with hypotaurine alone.
(b) Intracellular hypotaurine was detected by HPLC and normalized to total protein. Graphs show the means and error bars represent SD of 3 replicates
in 3 independent experiments. For comparison using presence of hypotaurine as control: *P < 0.05, for comparison using presence of hypotaurine and
taurine as control: #P < 0.05, ##P < 0.01 (Student t-test).
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ROS on cell viability was analyzed by Neutral Red Uptake
(NRU) assay, which shows the highest predictability of human
phototoxicity of all the in vitro assays evaluated (30,32). HaCaT
cells were irradiated with UVA at 5, 10 or 15 Jcm-2 alone
(Fig. 5), with the two higher doses showing a statistically sig-
nificant cytotoxic effect on cell viability 91.7  1.9 %
(#P < 0.05) and 84.1  2.4 % (###P < 0.005), respectively.
Dark control (no UVA) with hypotaurine (0.05–40 mM) for
24 h was performed (Fig. 3b (●)) showing no significant effect
on cell viability. The pre-incubation of cells with hypotaurine
before UVA irradiation significantly reduced the cytotoxic
effects of UVA at hypotaurine concentrations between 0.5 and
20 mM at all the three UVA doses investigated and at all
hypotaurine concentrations used, when irradiated with 15 Jcm-2
UVA. The maximum viability reached (***P < 0.005) follow-
ing irradiation with 5 Jcm-2 UVA was at 2.5 mM of hypotau-
rine (112.8  2.6 %), at 10 Jcm-2 was at 5 mM of hypotaurine
(104.7  2.2 %), and at 15 Jcm-2 was at 5 mM of hypotaurine
(97.6  2.8 %; Fig. 5).
Intracellular hypotaurine levels decrease after UVA
irradiation
To assess hypotaurine levels in cells after UVA irradiation,
HaCaT cells, which had been pre-treated for 24 h with 5 mM
hypotaurine, were irradiated with 0, 5, 10 or 15 Jcm-2 UVA and
intracellular hypotaurine and taurine concentrations were deter-
mined by HPLC analysis 24 h after irradiation. The level of
hypotaurine was reduced at all three UVA doses compared to
the non-irradiated control (9.87  0.8 nmol mg1 protein;
Fig. 6). The level of taurine was reduced at highest doses of
UVA (10 and 15 Jcm-2) compared to the non-irradiated control
(102  10 nmol mg1 protein; Fig. 6 insert).
DISCUSSION
Hypotaurine has already been included as an ingredient in cos-
metic preparations despite a lack of published evidence to sup-
port its mechanism of action and role as an anti-photoageing
agent (8,9). The current study sought to evaluate the effect of
supplemental hypotaurine uptake in HaCaT cells on cytotoxicity
in the presence and absence of UVA irradiation, in order to
assess whether there was evidence to support the rationale for
the addition of hypotaurine to topical sunscreen and cosmetic
preparations. The role of taurine, the oxidative form of hypotau-
rine, has been shown to have a positive effect on cell survival
attributed to its osmolyte activity (19,20) and to have a photopro-
tective effect against UV-induced damage via regulating the
release of platelet-activating factor from the membrane of UVB-
irradiated cells (21). To our knowledge, this is the first study that
has investigated whether hypotaurine, which has been well stud-
ied for its antioxidant effects in vitro, including kinetic experi-
ments using enzyme and radiolysis analysis and ex vivo
experiments in rat placental trophoblasts and human skin fibrob-
lasts (14–17), could have photoprotective effects. Approaches to
the prevention of photoageing and skin cancer have included a
prominent focus on limiting ROS production generated by UVA
and counteracting oxidative damage, through the use of antioxi-
dant agents, such as vitamins E and C, b-carotene and retinoids,
which are capable of interacting with ROS and reducing their
formation and impact (8,33).
We have shown that supplemental hypotaurine is taken up by
keratinocytes with an increase of ~ 30–fold above basal levels
following 24 h incubation and that this remained elevated for at
least 48 h after removal of supplemental hypotaurine from the
culture media (Fig. 1a). Hypotaurine supplementation was asso-
ciated with a small but significant increase in cell viability at the
48 h washout timepoint. A possible reason for this could be due
to effects on antioxidant expression regulated by Nrf2 down-
stream of hypotaurine. It has been reported that in HT22 cells,
taurine promotes Nrf2 nuclear translocation and induces heme
Figure 5. Hypotaurine supplementation protects HaCaT cells during
UVA irradiation. HaCaT cells were treated for 24 h  hypotaurine from
0.05 to 40 mM and irradiated  UVA at 5, 10 and 15 Jcm-2. Cell viabil-
ity was determined by NRU assay 24 h after UVA irradiation and nor-
malized to ctr. Graph shows the means, and error bars represent SD of 6
replicates in 3 independent experiments. Dark control (no UVA) with
hypotaurine from 0.05 to 40 mM in Fig. 3b (●). For comparison using
for each UVA dose 0 mM as control versus hypotaurine from 0.05 to
40 mM: *P < 0.05, **P < 0.01 and ***P < 0.005, for comparison using
ctr as control versus 0 mM only: #P < 0.05, ###P < 0.005 (ANOVA
test).
Figure 6. Intracellular hypotaurine levels decrease after UVA irradiation.
HaCaT cells were treated for 24 h with hypotaurine 5 mM and irradi-
ated  UVA at 5, 10 or 15 Jcm-2. 24 h after irradiation, intracellular
hypotaurine and taurine (insert) was detected by HPLC and levels nor-
malized to total protein. Graph shows the means and error bars represent
SD of 2 replicates in 2 independent experiments. For comparison using
dark as control: P > 0.05 (Student t-test).
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oxygenase-1 expression and can improve resistance to oxidative
damage induced by glutamate (34). Although this pathway has
been shown to be effective following taurine supplementation in
HT22 cells, it remains to be investigated and verified for
hypotaurine. Hypotaurine uptake into cells was time-dependent
and reached a maximum level after 10 h of incubation and
remained significantly above control levels for the duration of
the 72 h incubation period (Fig. 2). We have also demonstrated
for the first time that hypotaurine uptake in keratinocytes is con-
centration-dependent, with intracellular levels increasing expo-
nentially at supplementation concentrations in excess of 2.5 mM
(Fig. 3a).
Hypotaurine supplementation showed a small but significant
positive impact on cell viability 48 h after its removal from
media (Fig. 1b), although this was not statistically significant at
24 h. In contrast, higher concentrations of hypotaurine supple-
mentation negatively impacted on cell viability, especially above
20 mM (Fig. 3b), when determined using the MTT assay. How-
ever, when using the NRU assay as an endpoint, there was no
significant hypotaurine dose-dependent impact on cell viability
seen when compared with untreated cells. In addition, using try-
pan blue exclusion as an indicator of live cell number after
hypotaurine treatment did not show a change in viable cell num-
ber indicating that cells were alive and possessed intact cell
membranes. The discrepancy in the results obtained using MTT
and NRU assays could be explained through the mechanism of
action for each assay: the MTT assay assesses both cell survival
and cell growth by measuring the activity of mitochondrial dehy-
drogenases (29), whilst the NRU assay is based on the incorpora-
tion of neutral red into the lysosomes of viable cells (32). These
results suggest that high concentrations of hypotaurine could
affect mitochondrial dehydrogenase activities without causing
cell death and therefore show a negative effect on the cell viabil-
ity that is not apparent when a different assay is used.
We also investigated the possible mechanisms involved in the
uptake of hypotaurine in HaCaT cells. The presence of TAUT in
different tissues, especially in human skin (25,26), suggests a
possible mechanism for tissue-specificity of hypotaurine trans-
portation into cells. Our results indicate that intracellular
hypotaurine concentration was detected after 24 h of incubation
(9.87  0.8 nmol mg1 protein), albeit at much lower levels
than in the culture media (5 mM; Figs. 1a and 3a), although for-
mal comparison was not feasible due to the differences in units
of measurement. Interestingly, when taurine was present with
hypotaurine in the incubation medium, the hypotaurine uptake
detected in cells was significantly lower than with hypotaurine
alone (Fig. 4b), suggesting competition for the transporter
between taurine and hypotaurine and a consequent decrease in
hypotaurine uptake. This would be in line with the results
reported by Grafe and colleagues, where [3H]taurine uptake in
keratinocytes was inhibited equally by unlabeled hypotaurine,
taurine or b-alanine (25). The residual amount of hypotaurine
uptake in the presence of taurine was still significant compared
to basal hypotaurine levels in cells, suggesting that taurine pres-
ence does not fully inhibit the hypotaurine uptake. This would
be worth studying further through the use of in vivo models,
such as the taurine transporter-knockout mouse, which exhibits
extensive taurine depletion in tissue (35). The 24 h pre-incuba-
tion of cells with PPG, a cysteinesulfinate decarboxylase inhibi-
tor that inhibits the decarboxylation of cysteinesulfinate to
hypotaurine (31), followed by washout before hypotaurine
addition, enhanced the uptake of hypotaurine into HaCaT cells
compared to incubation with hypotaurine alone (~2-fold;
Fig. 4b). Similarly, the 24 h pre-incubation of cells with b-ala-
nine, an amino acid that has a similar affinity to TAUT as
hypotaurine and taurine (25), followed by washout before
hypotaurine addition, showed a ~ 2-fold increment of the uptake
of hypotaurine vs hypotaurine alone (Fig. 4b). These findings
suggest that 24 h pre-incubation with inhibitor of the metabolic
synthesis as well as with competitor of TAUT increases the
demand for external hypotaurine uptake.
Exposure of cells to UVA generates ROS and consequently
leads to oxidative damage that can result in cell death (28).
Our data demonstrate that the dose-dependent decrease in cell
viability caused by UVA irradiation of HaCaT cells can be
prevented by pre-exposure supplementation with hypotaurine.
This protective effect of hypotaurine against UVA-induced
cytotoxicity was apparent at all three UVA doses tested, and a
hypotaurine dose-dependent effect was also observed. Interest-
ingly, the hypotaurine protective effect was most significant at
2.5 mM both  UVA irradiation (Fig. 5), with statistically sig-
nificant protection against UVA-induced cytotoxicity when cells
were pre-incubated with hypotaurine between 0.5 and 20 mM
at all the UVA doses examined. These findings suggest that
despite the reduction in viability seen at the higher concentra-
tions of hypotaurine supplementation in the absence of UVA
exposure (Fig. 3b), there is potential for a beneficial effect of
supplementing with hypotaurine to protect against UVA-in-
duced cell damage. Our data also demonstrate a reduction in
intracellular hypotaurine levels after UVA irradiation, suggest-
ing that it is depleted in response to UVA exposure (Fig. 6).
As hypotaurine itself does not absorb radiation in the UVA
region (36), this cannot be a consequence of a direct photo-
chemical interaction between hypotaurine and UVA. On the
contrary, hypotaurine is well known to interact with ROS and
act as an antioxidant (15,27). The taurine level detected did
not significantly change in the context of hypotaurine depletion,
probably due to lack of sensitivity of detection at these levels,
as there were 10-fold higher levels of intracellular taurine com-
pared to hypotaurine present in the cells after treatment with
5 mM hypotaurine and moreover, taurine levels are reduced at
higher UVA doses. This decrease seems to be related to the
well-known taurine interaction with UV as osmolyte (18-22).
Our data therefore support an interaction between hypotaurine
and ROS generated by UVA irradiation of cells, resulting in
its oxidation to taurine as the underlying mechanism of protec-
tion and further investigations such as intracellular ROS detec-
tion using a fluorescent probe would help clarify the role of
hypotaurine as a protective agent.
CONCLUSION
In conclusion, the data we present here demonstrate that sup-
plemental hypotaurine is taken up by cultured human ker-
atinocytes and has a positive effect on cell viability and a
protective effect against UVA-induced cytotoxicity, indicating a
possible interaction between hypotaurine and ROS produced
following UVA exposure. These results support the potential
for hypotaurine to be an effective photoprotective ingredient in
sunscreen and cosmetic formulations in order to reduce UVA-
induced cell damage and prevent photoageing and this warrants
further investigation.
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